Organization
Bristol-Myers Squibb, Uxbridge, United Kingdom
2 abstracts
Abstract
ANTI-CCP IS AN INDEPENDENT PREDICTOR OF 12-MONTH EULAR RESPONSE IN PATIENTS WITH RA TREATED WITH ABATACEPT Org: Sint Maartenskliniek and Radboud UMC, Radboud UMC, Sint Maartenskliniek, Nijmegen, Netherlands, Bristol-Myers Squibb, Uxbridge, United Kingdom, Bristol-Myers Squibb, Princeton, United States,
Abstract
ABATACEPT SHOWS BETTER SUSTAINABILITY THAN TNF INHIBITORS WHEN USED FOLLOWING INITIAL BIOLOGIC DMARD FAILURE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 8 YEARS OF REAL-WORLD OBSERVATIONS FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY Org: Rheumatology, Institut de recherche en rhumatologie de Montréal (IRRM), Montréal, Rheumatology, Centre d'ostéoporose et de rhumatologie de Québec (CORQ), Québec, Canada, Bristol-Myers Squibb, Princeton, United States, Bristol-Myers Squibb, Montréal, Canada, Bristol-Myers Squibb, Uxbridge, United Kingdom,